{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:36:19Z","timestamp":1777610179874,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.bbrc.2013.02.086","type":"journal-article","created":{"date-parts":[[2013,3,5]],"date-time":"2013-03-05T13:01:03Z","timestamp":1362488463000},"page":"305-310","source":"Crossref","is-referenced-by-count":30,"title":["Investigating the anti-mineralocorticoid properties of synthetic progestins used in hormone therapy"],"prefix":"10.1016","volume":"433","author":[{"given":"Donita","family":"Africander","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renate","family":"Louw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet P.","family":"Hapgood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2013.02.086_b0005","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.steroids.2011.03.001","article-title":"Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception","volume":"76","author":"Africander","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.bbrc.2013.02.086_b0010","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1210\/en.2013-1066","article-title":"Immunosuppressive biological mechanisms support reassessment of use of the injectable contraceptive medroxyprogesterone acetate","volume":"154","author":"Hapgood","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbrc.2013.02.086_b0015","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.tips.2004.09.005","article-title":"Not all progestins are the same: implications for usage","volume":"25","author":"Hapgood","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbrc.2013.02.086_b0020","doi-asserted-by":"crossref","unstructured":"F.Z. Stanczyk, J.P. Hapgood, S. Winer, D.R. Mishell Jr., Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects. Endocr Rev. 2012. [Epub ahead of print].","DOI":"10.1210\/er.2012-1008"},{"key":"10.1016\/j.bbrc.2013.02.086_b0025","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.ajog.2003.09.033","article-title":"A comparative review of the risks and benefits of hormone replacement therapy regimens","volume":"190","author":"Warren","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.bbrc.2013.02.086_b0030","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2013.02.086_b0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1473-3099(11)70247-X","article-title":"Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study","volume":"12","author":"Heffron","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bbrc.2013.02.086_b0040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.bbrc.2013.02.086_b0045","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1161\/01.CIR.0000030940.73167.4E","article-title":"Long-term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance","volume":"106","author":"Sorensen","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2013.02.086_b0050","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1124\/pr.58.4.9","article-title":"International union of pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors","volume":"58","author":"Lu","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbrc.2013.02.086_b0055","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.pcad.2009.12.003","article-title":"Aldosterone and mineralocorticoid receptors in the cardiovascular system","volume":"52","author":"Funder","year":"2010","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.bbrc.2013.02.086_b0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.tem.2012.09.004","article-title":"Aldosterone and cardiovascular disease: the heart of the matter","volume":"24","author":"He","year":"2013","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2013.02.086_b0065","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1210\/en.2006-1438","article-title":"Early aldosterone-regulated genes in cardiomyocytes: clues to cardiac remodeling?","volume":"148","author":"Fejes-T\u00f3th","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbrc.2013.02.086_b0070","doi-asserted-by":"crossref","first-page":"9449","DOI":"10.1074\/jbc.274.14.9449","article-title":"Specific androgen receptor activation by an artificial coactivator","volume":"274","author":"Sui","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2013.02.086_b0075","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.3037703","article-title":"Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor","volume":"237","author":"Arriza","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2013.02.086_b0080","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.mce.2010.06.007","article-title":"Role of ligand-dependent GR phosphorylation and half-life in determination of ligand-specific transcriptional activity","volume":"327","author":"Avenant","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbrc.2013.02.086_b0085","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1172\/JCI117943","article-title":"Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans","volume":"95","author":"Bamberger","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2013.02.086_b0090","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2013.02.086_b0095","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.contraception.2011.06.006","article-title":"Differential regulation of endogenous pro-inflammatory cytokine genes by medroxyprogesterone acetate and norethisterone acetate in cell lines of the female genital tract","volume":"84","author":"Africander","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.bbrc.2013.02.086_b0100","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.thromres.2003.09.023","article-title":"Expression of type-1 plasminogen activator inhibitor in the kidney of diabetic rat models","volume":"111","author":"Hagiwari","year":"2003","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bbrc.2013.02.086_b0105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0922-4106(93)90072-H","article-title":"Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands","volume":"247","author":"Rupprecht","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2013.02.086_b0110","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3109\/09513599909167574","article-title":"The pharmacological profile of a novel norpregnance progestin (trimegestone)","volume":"13","author":"Philibert","year":"1999","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.bbrc.2013.02.086_b0115","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0039-128X(03)00142-9","article-title":"The preclinical biology of a new potent and selective progestin: trimegestone","volume":"68","author":"Winneker","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.bbrc.2013.02.086_b0120","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1126\/science.289.5476.119","article-title":"Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy","volume":"289","author":"Geller","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2013.02.086_b0125","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.steroids.2007.10.003","article-title":"Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile","volume":"73","author":"Sasagawa","year":"2008","journal-title":"Steroids"},{"key":"10.1016\/j.bbrc.2013.02.086_b0130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1783\/147118903101197188","article-title":"Newer progestogens","volume":"29","author":"Rowlands","year":"2003","journal-title":"J. Fam. Plann. Reprod. Health Care."},{"key":"10.1016\/j.bbrc.2013.02.086_b0135","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1126\/science.8382376","article-title":"Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element","volume":"259","author":"Pearce","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2013.02.086_b0140","first-page":"230","article-title":"Aldosterone and PAI-1: implications for renal injury","volume":"15","author":"Brown","year":"2002","journal-title":"J. Nephrol."},{"key":"10.1016\/j.bbrc.2013.02.086_b0145","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2337\/diabetes.52.2.442","article-title":"Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study","volume":"52","author":"Engstrom","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2013.02.086_b0150","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mce.2005.07.001","article-title":"Synthetic progestins used in HRT have different glucocorticoid agonist properties","volume":"242","author":"Koubovec","year":"2005","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbrc.2013.02.086_b0155","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X13003598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X13003598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T04:05:28Z","timestamp":1539835528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X13003598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0006291X13003598"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2013.02.086","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}